Search Results
Results for: COVINGTON AND BURLING (Save this search)
Number of Results: 97
Renesas to Acquire Integrated Device Technology in Deal Valued JPY 733bn
11 September 2018 - Japan-based semiconductor solutions company Renesas Electronics Corp. (TSX: 6723) has agreed to acquire California, US-based analog mixed-signal products provid...

RENESAS TO ACQUIRE INTEGRATED DEVICE TECHNOLOGY IN DEAL VALUED JPY 733M
Japan-based semiconductor solutions company Renesas Electronics Corp. (TSX: 6723) has agreed to acquire California, US-based analog mixed-signal products provider Integrated Device...

Radisys Wins Shareholder Nod for USD 65m Reliance Industries Buyout
6 September 2018 - Shareholders of US-based telecom solutions provider Radisys Corp. (NASDAQ: RSYS) have voted to approve proposals related to the previously announced merger agree...

RADISYS WINS SHAREHOLDER NOD FOR USD 65M RELIANCE INDUSTRIES BUYOUT
Shareholders of US-based telecom solutions provider Radisys Corp. (NASDAQ: RSYS) have voted to approve proposals related to the previously announced merger agreement under which Ra...

Emergent BioSolutions AcquiresAdapt Pharma and Its Flagship Product Narcan Nasal Spray
30 August 2018 - US-based life sciences company Emergent BioSolutions Inc. (NYSE: EBS) has entered into an agreement to acquire Irish drugmaker Adapt Pharma and its flagship produc...

EMERGENT BIOSOLUTIONS ACQUIRES ADAPT PHARMA AND ITS FLAGSHIP PRODUCT NARCAN NASAL SPRAY
US-based life sciences company Emergent BioSolutions Inc. (NYSE: EBS) has entered into an agreement to acquire Irish drugmaker Adapt Pharma and its flagship product Narcan (na...

Emergent BioSolutions to Acquire PaxVax Speciality Vaccines from Cerberus Capital
15 August 2018 - Maryland, US-based biopharmaceutical company Emergent BioSolutions (NYSE: EBS) has agreed to acquire California, US-based PaxVax a provider of vaccines against inf...

Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax for USD 270m in Cash
13 August 2018 - US-based global life sciences company Emergent BioSolutions Inc. (NYSE: EBS) has entered into an agreement to acquire specialty vaccines developer PaxVax for an al...

EMERGENT BIOSOLUTIONS TO ACQUIRE SPECIALTY VACCINES COMPANY PAXVAX FOR USD 270M IN CASH
US-based global life sciences company Emergent BioSolutions Inc. (NYSE: EBS) has entered into an agreement to acquire specialty vaccines developer PaxVax for an all-cash considerat...

You can compare news articles by clicking on the tick buttons
1   2   3   4   5   6   7   8   9   10   >